𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells

✍ Scribed by Therese H Hemström; Margareta Sandström; Boris Zhivotovsky


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
696 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Non‐small cell lung cancer cells (NSCLC) are more resistant to anticancer treatment as compared with other types of cancer cells. Recently (Hemström et al., Exp Cell Res 2005;305:200–13) we showed that apoptosis of U1810 NSCLC cells induced by the staurosporine analog PKC 412 correlated with inhibition of Akt and ERK1/2, suggesting the involvement of these kinases in cell survival. Here we investigated the contribution of the PI3‐kinase/Akt and MEK/ERK pathways to survival of NSCLC cells. The two signaling pathways were studied by using different combinations of the PI3‐kinase inhibitors LY‐294002 and wortmannin, the Akt activator Ro 31‐8220, the MEK inhibitor PD 98059 and PKC 412. PI3‐kinase inhibitors induced apoptosis‐like death in U1810 cells. H157 cells in general were relatively resistant to PI3 kinase/Akt inhibitors yet these compounds sensitized cells to the DNA‐damaging drug VP‐16, while Ro 31‐8220 could not. PD 98059 only had a sensitizing effect on H157 cells when combined with PI3‐kinase inhibition and VP‐16. Morphological data indicated that LY‐294002 and PKC 412 induced cell death at anaphase and metaphase, respectively, suggesting death by mitotic catastrophe. Analyzes of cells blocked in G2/M‐phase by nocodazol revealed that LY‐294002 increased, while PKC 412 decreased histone H3 phosphorylation, suggesting that LY‐294002 allowed, while PKC 412 inhibited cells to leave M‐phase. Flow cytometric analysis of cell cycle distribution demonstrated that LY‐294002 allowed cells to leave G2/M phase, while PKC 412 inhibited cytokinesis, resulting in formation of multinucleated cells. These results indicate that sensitization of NSCLC cells by PI3‐kinase inhibition involves interplay between cell cycle regulation, mitotic catastrophe and apoptosis. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Enhanced cytotoxicity induced by gefitin
✍ Maarten L. Janmaat; José A. Rodriguez; Mariëlle Gallegos-Ruiz; Frank A.E. Kruyt; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 371 KB

## Abstract In this study, we have characterized a panel of NSCLC cell lines with differential sensitivity to gefitinib for activating mutations in __egfr__, __pik3ca__, and __k‐ras__, and basal protein expression levels of PTEN. The __egfr__ mutant NSCLC cell line H1650 as well as the __egfr__ wil

Disruption of the RB pathway and cell-pr
✍ Hisaichi Tanaka; Yoshitaka Fujii; Hirohisa Hirabayashi; Shinichiro Miyoshi; Masa 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 407 KB 👁 2 views

The pathway consisting of retinoblastoma protein (pRB), cyclin D1 and p16 (RB pathway) which is involved in the phosphorylation of pRB plays an important role in G 1 /S progression. The disruption of this RB pathway has been reported in several types of human neoplasm. An immunohistochemical study o

Magnolol induces apoptosis via inhibitin
✍ Dae-Hee Lee; Miroslaw-Jerzy Szczepanski; Yong J. Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

## Abstract We observed that treatment of prostate cancer cells for 24 h with magnolol, a phenolic component extracted from the root and stem bark of the oriental herb __Magnolia officinalis__, induced apoptotic cell death in a dose‐ and time‐dependent manner. A sustained inhibition of the major su

The role of the PI3K-AKT kinase pathway
✍ Ling Xue; Leslie Chiang; Chulho Kang; Astar Winoto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

## Abstract The PI3K‐AKT pathway can mediate diverse biological responses and is crucial for optimal immune responses and lymphocyte development. Deletion of PI3K subunits or AKT leads to blockage of T‐cell development at the TCR‐β checkpoint. Studies with over‐expression of constitutively activate

Phosphoinositide 3-kinase/Akt pathway pl
✍ Hong-Gang Yu; Yao-Wei Ai; Liang-Liang Yu; Xiao-Dong Zhou; Jin Liu; Jun-Hua Li; X 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 663 KB

## Abstract The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3‐kinase (PI3K)/Akt pathway in the development of chemoresistance in gastric cancer. In the present study, elevated Akt expression